Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis
- 1 November 1982
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 31 (11), 1147-1152
- https://doi.org/10.1016/0026-0495(82)90166-4
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects.BMJ, 1980
- Estrogen Use in Postmenopausal Women — Costs, Risks, and BenefitsNew England Journal of Medicine, 1980
- Aging, Natural Death, and the Compression of MorbidityNew England Journal of Medicine, 1980
- The National Cost of Acute Care of Hip Fractures Associated with OsteoporosisPublished by Wolters Kluwer Health ,1980
- High density lipoproteins during hypolipidemic therapyAtherosclerosis, 1980
- High-density lipoprotein-cholesterol in survivors of myocardial infarctionJAMA, 1979
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of manAtherosclerosis, 1978
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977